Interojo Inc. (KOSDAQ:119610)
13,930
+10 (0.07%)
Sep 18, 2026, 3:30 PM KST
Interojo Market Cap
Interojo has a market cap or net worth of 156.48 billion as of September 18, 2026. Its market cap has decreased by -30.06% in one year.
Market Cap
156.48B
Enterprise Value
184.98B
Revenue
124.14B
Ranking
n/a
PE Ratio
9.63
Stock Price
13,930.00
ChartMarket Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 156.48B, an increase of 253.32%. That is a compound annual growth rate of 8.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 156.48B | -14.37% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.55T |
| Celltrion | 41.19T |
| ALTEOGEN | 17.69T |
| Samsung Epis Holdings | 8.26T |
| GC Genome | 165.56B |
| Samil Pharmaceutical Co.,Ltd | 159.64B |
| Daihan Pharmaceutical | 155.23B |
| Ilsung Is | 151.92B |